FRANKFURT (dpa-AFX Broker) - The imminent legalization of cannabis in Germany is driving Synbiotic shares < > upwards. After a long struggle by the federal government, it was announced on Friday that the final details on the legalization of cannabis have been clarified and a law can come into force on April 1. In addition to Synbiotic, Cantourage is also a profiteer on the stock market.

On Friday, Synbiotic's share price shot up by 36 percent. On Monday, this was followed by a 23 percent increase. Cantourage, a company specializing more in medical applications, initially rose by 11 percent on Friday and has now jumped 21 percent.

Synbiotic in particular has been an object of speculation over the past two years, but the share price had recently fallen sharply due to the dwindling enthusiasm for the topic. Now, however, home cultivation and possession of certain quantities of the drug are to be permitted for adults from April 1, 2024./tih/mis

-----------------------

dpa-AFX Broker - the Trader News from dpa-AFX

-----------------------